Skip to Main Content

Latest News

Efficacy of Neoadjuvant/Adjuvant Pembrolizumab in TNBC

Lajos Pusztai, MD, DPhil, discusses multiple analyses of the phase 3 KEYNOTE-522 clinical trial of pembrolizumab plus chemotherapy administered in the neoadjuvant or adjuvant setting to patients with triple-negative breast cancer versus placebo plus chemotherapy.

Source: Targeted Oncology
Read more